Novozymes A/S (NVZMY) Dividend Yield, Date & History $69.75 -0.68 (-0.97%) As of 05/23/2025 03:59 PM Eastern Add Compare Share Share Dividend Stock AnalysisAnalyst ForecastsChartDividendHeadlinesSEC FilingsShort InterestBuy This Stock Novozymes A/S Dividend SummaryDividend Yield1.08%Annual Dividend$0.75Recent Dividend Payment Apr. 23 Dividend Payout Ratio 47.47% Novozymes A/S (NVZMY) pays an annual dividend of $0.75 per share, with a dividend yield of 1.08%. The most recent payment of $0.3758 per share was paid on Wednesday, April 23, to investors who owned the stock before the ex-dividend date of Monday, April 7. The company currently pays out 47.47% of its earnings and 78.31% of its cash flow as dividends. Get Dividend Stock Ideas Daily Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news. Enter your email to sign up for newsletter Sign Up Skip Charts & View Dividend HistoryNVZMY Dividend Payments by QuarterDividend Payments by Quarter Chart DescriptionThe chart below displays up to four years of Novozymes A/S's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.Open Novozymes A/S in Dividend Calculator NVZMY Dividend Yield Over TimeDividend Yield Over Time Chart DescriptionThe chart below tracks Novozymes A/S's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.Open Novozymes A/S in Dividend Yield Calculator Novozymes A/S vs. The CompetitionCompare Novozymes A/S's annual dividend, yield, and 3-year growth rate with averages for Materials and OTCMKTS companies to evaluate its performance against the market.TypeNovozymes A/SMaterials CompaniesOTCMKTS CompaniesAnnual Dividend$0.75$0.17$27.13Dividend Yield1.08%5.07%18.50%Novozymes A/S Dividend Payout RatioDividend payout ratios express the dividend as a percentage of another metric, such as earnings or cash flow, and can be used to assess dividend sustainability.TypePayout RatioBased on Trailing 12 Months of Earnings47.47%Based on This Year's Estimate41.21%Based on Next Year's Estimate35.05%Based on Cashflow78.31% Novozymes A/S Dividend History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years All Time Time Frame * Start Date * End Date AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date3/10/2025$0.3758+$0.2079123.88%4/7/20254/7/20254/23/20258/29/2024$0.1678-$0.01759.44%9/9/20249/9/20249/18/20244/11/2024$0.1853-$0.198751.73%5/1/20245/2/20245/20/202410/12/2023Annual$0.3840-$0.205834.90%10/20/202310/23/202311/1/2023This table shows Novozymes A/S's dividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time. Novozymes A/S Dividend - Frequently Asked Questions What is Novozymes A/S's dividend yield? The current dividend yield for Novozymes A/S is 1.08%. Learn more on NVZMY's dividend yield history. How much is Novozymes A/S's annual dividend? The annual dividend for NVZMY shares is $0.75. Learn more on NVZMY's annual dividend history. When was Novozymes A/S's most recent dividend payment? Novozymes A/S's most recent dividend payment of $0.3758 per share was made to shareholders on Wednesday, April 23, 2025. When was Novozymes A/S's most recent ex-dividend date? Novozymes A/S's most recent ex-dividend date was Monday, April 7, 2025. When did Novozymes A/S last increase or decrease its dividend? The most recent change in the company's dividend was an increase of $0.2079 on Monday, March 10, 2025. What is Novozymes A/S's dividend payout ratio? The dividend payout ratio for NVZMY is: 47.47% based on the trailing year of earnings 41.21% based on this year's estimates 35.05% based on next year's estimates 78.31% based on cash flow Is Novozymes A/S a good dividend stock? Novozymes A/S's dividend yield of 1.10% is lower than the average Basic Materials company that issues a dividend. Novozymes A/S's dividend payout ratio of 47.47% is at a healthy, sustainable level, below 75% of its earnings. Looking at the stock as a whole, market analysts rate Novozymes A/S stock as a Buy, with forecasts suggesting positive growth potential despite some reservations. More Dividend Resources from MarketBeat Related Companies BioNTech Dividend Qiagen Dividend Bio-Techne Dividend Dividend Tools Dividend Announcements Dividend Calculator Dividend Capture Stocks Dividend Cuts Dividend Increases Dividend Investing Guide Dividend Newsletter Dividend Payout Ratio Calculator Dividend Screener Dividend Stocks Overview Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Special Dividends Stock Lists Best Dividend Stocks Blue Chip Stocks Cheap Dividend Stocks Dividend Achievers Dividend Aristocrats Dividend Challengers Dividend Champions Dividend Contenders Dividend ETFs Dividend Kings High-Yield REITs High-Yield Stocks Monthly Dividend Stocks Real Estate Investment Trusts Latest Articles Pfizer's 7.5% Dividend: Income Haven or House of Cards?3 Dividend-Friendly Consumer Discretionary Stocks With UpsideIs Verizon a Buy? Q1 Results and Solid Dividend Make Bullish CaseDividends & Stability: 3 Consumer Staples Giants Boost Payouts3 Dividend Kings Outshining the Market in 2025Altria’s Resilient Strategy Keeps It a Top Dividend Play in 2025Dividend King Kimberly-Clark Is a Good Buy in 2025Medtronic: A Dividend Aristocrat With Stability and InnovationSnap-on: Buy This Must-Own Dividend Stock While It’s Down More Dividend News This page (OTCMKTS:NVZMY) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novozymes A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novozymes A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
